Jatin Shah - Net Worth and Insider Trading
Jatin Shah Net Worth
The estimated net worth of Jatin Shah is at least $111,340 dollars as of 2024-11-13. Jatin Shah is the EVP, Chief Medical Officer of Karyopharm Therapeutics Inc and owns about 129,450 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $111,340. Details can be seen in Jatin Shah's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jatin Shah has not made any transactions after 2022-02-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jatin Shah
Jatin Shah Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jatin Shah owns 1 companies in total, including Karyopharm Therapeutics Inc (KPTI) .
Click here to see the complete history of Jatin Shah’s form 4 insider trades.
Insider Ownership Summary of Jatin Shah
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2022-02-17 | EVP & Chief Medical Officer |
Jatin Shah Latest Holdings Summary
Jatin Shah currently owns a total of 1 stock. Jatin Shah owns 129,450 shares of Karyopharm Therapeutics Inc (KPTI) as of February 17, 2022, with a value of $111,340.
Latest Holdings of Jatin Shah
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2022-02-17 | 129,450 | 0.86 | 111,340 |
Holding Weightings of Jatin Shah
Jatin Shah Form 4 Trading Tracker
According to the SEC Form 4 filings, Jatin Shah has made a total of 7 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years, including 1 buys and 6 sells. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 1,306 shares on February 17, 2022, which brought Jatin Shah around $15,829.
Insider Trading History of Jatin Shah
- 1
Jatin Shah Trading Performance
GuruFocus tracks the stock performance after each of Jatin Shah's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jatin Shah is -34.25%. GuruFocus also compares Jatin Shah's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jatin Shah within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jatin Shah's insider trading performs compared to the benchmark.
Performance of Jatin Shah
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.09 | | | | | |
| Relative Return to S&P 500(%) | 12.23 | | | | | |
Jatin Shah Ownership Network
Ownership Network List of Jatin Shah
Ownership Network Relation of Jatin Shah
Jatin Shah Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Jatin Shah is the EVP & Chief Medical Officer of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include director & President and CEO Richard A. Paulson , EVP & CFO & Treasurer Michael Mason , and SVP Sales & Commercial Ops Sohanya Roshan Cheng .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Jatin Shah made no insider transaction in Karyopharm Therapeutics Inc (KPTI). Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 165,682 shares made by Richard A. Paulson , a net sale of 55,845 shares made by Michael Mason , and a net sale of 41,559 shares made by Sohanya Roshan Cheng .
In summary, during the past 3 months, insiders sold 27,326 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 27,326 shares. During the past 18 months, 2,078,182 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 2,037,042 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Jatin Shah Mailing Address
Above is the net worth, insider trading, and ownership report for Jatin Shah. You might contact Jatin Shah via mailing address: C/o Karyopharm Therapeutics, Inc., 85 Wells Avenue, Newton Ma 02459.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
